-
Loading metrics
Open Access
Peer-reviewed
Research Article
Interferon alpha treatment stimulates interferon gamma expression in type I NKT cells and enhances their antiviral effect against hepatitis C virus
-
Eisuke Miyaki,
Affiliations Department of Gastroenterology and Metabolism, Applied Life Science, Institute of Biomedical & Health Science, Hiroshima University, Hiroshima, Japan, Liver Research Project Center, Hiroshima University, Hiroshima, Japan
⨯ -
Nobuhiko Hiraga,
Affiliations Department of Gastroenterology and Metabolism, Applied Life Science, Institute of Biomedical & Health Science, Hiroshima University, Hiroshima, Japan, Liver Research Project Center, Hiroshima University, Hiroshima, Japan
⨯ -
Michio Imamura,
Affiliations Department of Gastroenterology and Metabolism, Applied Life Science, Institute of Biomedical & Health Science, Hiroshima University, Hiroshima, Japan, Liver Research Project Center, Hiroshima University, Hiroshima, Japan
⨯ -
Takuro Uchida,
Affiliations Department of Gastroenterology and Metabolism, Applied Life Science, Institute of Biomedical & Health Science, Hiroshima University, Hiroshima, Japan, Liver Research Project Center, Hiroshima University, Hiroshima, Japan
⨯ -
Hiromi Kan,
Affiliations Department of Gastroenterology and Metabolism, Applied Life Science, Institute of Biomedical & Health Science, Hiroshima University, Hiroshima, Japan, Liver Research Project Center, Hiroshima University, Hiroshima, Japan
⨯ -
Masataka Tsuge,
Affiliations Department of Gastroenterology and Metabolism, Applied Life Science, Institute of Biomedical & Health Science, Hiroshima University, Hiroshima, Japan, Liver Research Project Center, Hiroshima University, Hiroshima, Japan
⨯ -
Hiromi Abe-Chayama,
Affiliations Department of Gastroenterology and Metabolism, Applied Life Science, Institute of Biomedical & Health Science, Hiroshima University, Hiroshima, Japan, Liver Research Project Center, Hiroshima University, Hiroshima, Japan
⨯ -
C. Nelson Hayes,
Affiliations Department of Gastroenterology and Metabolism, Applied Life Science, Institute of Biomedical & Health Science, Hiroshima University, Hiroshima, Japan, Liver Research Project Center, Hiroshima University, Hiroshima, Japan
⨯ -
Grace Naswa Makokha,
Affiliations Department of Gastroenterology and Metabolism, Applied Life Science, Institute of Biomedical & Health Science, Hiroshima University, Hiroshima, Japan, Liver Research Project Center, Hiroshima University, Hiroshima, Japan
⨯ -
Masahiro Serikawa,
Affiliations Department of Gastroenterology and Metabolism, Applied Life Science, Institute of Biomedical & Health Science, Hiroshima University, Hiroshima, Japan, Liver Research Project Center, Hiroshima University, Hiroshima, Japan
⨯ -
Hiroshi Aikata,
Affiliations Department of Gastroenterology and Metabolism, Applied Life Science, Institute of Biomedical & Health Science, Hiroshima University, Hiroshima, Japan, Liver Research Project Center, Hiroshima University, Hiroshima, Japan
⨯ -
Hidenori Ochi,
Affiliations Liver Research Project Center, Hiroshima University, Hiroshima, Japan, Laboratory for Digestive Diseases, Center for Genomic Medicine, The Institute of Physical and Chemical Research (RIKEN), Hiroshima, Japan
⨯ -
Yuji Ishida,
Affiliations Liver Research Project Center, Hiroshima University, Hiroshima, Japan, PhoenixBio Co., Ltd., Higashihiroshima, Japan
⨯ -
Chise Tateno,
Affiliations Liver Research Project Center, Hiroshima University, Hiroshima, Japan, PhoenixBio Co., Ltd., Higashihiroshima, Japan
⨯ -
Hideki Ohdan,
Affiliations Liver Research Project Center, Hiroshima University, Hiroshima, Japan, Department of Surgery, Division of Frontier Medical Science, Programs for Biomedical Research, Graduate School of Biomedical Science, Hiroshima University, Hiroshima, Japan
⨯ - [ ... ],
-
Kazuaki Chayama
* E-mail: chayama@hiroshima-u.ac.jp
Affiliations Department of Gastroenterology and Metabolism, Applied Life Science, Institute of Biomedical & Health Science, Hiroshima University, Hiroshima, Japan, Liver Research Project Center, Hiroshima University, Hiroshima, Japan, Laboratory for Digestive Diseases, Center for Genomic Medicine, The Institute of Physical and Chemical Research (RIKEN), Hiroshima, Japan
⨯ - [ view all ]
- [ view less ]
Interferon alpha treatment stimulates interferon gamma expression in type I NKT cells and enhances their antiviral effect against hepatitis C virus
- Eisuke Miyaki,
- Nobuhiko Hiraga,
- Michio Imamura,
- Takuro Uchida,
- Hiromi Kan,
- Masataka Tsuge,
- Hiromi Abe-Chayama,
- C. Nelson Hayes,
- Grace Naswa Makokha,
- Masahiro Serikawa
- Published: March 2, 2017
- https://doi.org/10.1371/journal.pone.0172412